Uluganyan Mahmut, Ekmekçi Ahmet, Murat Ahmet, Avşar Şahin, Ulutaş Türker Kemal, Uyarel Hüseyin, Bozbay Mehmet, Çiçek Gökhan, Karaca Gürkan, Eren Mehmet
Clinic of Cardiology, Kadirli Government Hospital; Osmaniye-Turkey.
Anatol J Cardiol. 2016 Jan;16(1):10-5. doi: 10.5152/akd.2015.5706.
Current guidelines recommend a serum potassium (sK) level of 4.0-5.0 mmol/L in acute myocardial infarction patients. Recent trials have demonstrated an increased mortality rate with an sK level of>4.5 mmol/L. The aim of this study was to figure out the relation between admission sK level and in-hospital and long-term mortality and ventricular arrhythmias.
Retrospectively, 611 patients with ST-elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention were recruited. Admission sK levels were categorized accordingly: <3.5, 3.5-<4, 4-<4.5, 4.5-<5, and ≥5 mmol/L.
The lowest in-hospital and long-term mortality occurred in patients with sK levels of 3.5 to <4 mmol/L. The long-term mortality risk increased for admission sK levels of >4.5 mmol/L [odds ratio (OR), 1.58; 95% confidence interval (CI) 0.42-5.9 and OR, 2.27; 95% CI 0.44-11.5 for sK levels of 4.5-<5 mmol/L and ≥5 mmol/L, respectively]. At sK levels <3 mmol/L and ≥5 mmol/L, the incidence of ventricular arrhythmias was higher (p=0.019).
Admission sK level of >4.5 mmol/L was associated with increased long-term mortality in STEMI. A significant relation was found between sK level of <3 mmol/L and ≥5 mmol/L and ventricular arrhythmias.
当前指南推荐急性心肌梗死患者的血清钾(sK)水平为4.0 - 5.0 mmol/L。近期试验表明,sK水平>4.5 mmol/L时死亡率会升高。本研究的目的是明确入院时sK水平与住院期间及长期死亡率和室性心律失常之间的关系。
回顾性纳入611例行直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死(STEMI)患者。入院时的sK水平据此分类:<3.5、3.5 - <4、4 - <4.5、4.5 - <5和≥5 mmol/L。
sK水平为3.5至<4 mmol/L的患者住院期间及长期死亡率最低。入院时sK水平>4.5 mmol/L时长期死亡风险增加[sK水平为4.5 - <5 mmol/L和≥5 mmol/L时的比值比(OR)分别为1.58;95%置信区间(CI)0.42 - 5.9和OR,2.27;95% CI 0.44 - 11.5]。sK水平<3 mmol/L和≥5 mmol/L时,室性心律失常的发生率较高(p = 0.019)。
STEMI患者入院时sK水平>4.5 mmol/L与长期死亡率增加相关。发现sK水平<3 mmol/L和≥5 mmol/L与室性心律失常之间存在显著关系。